Source: Cardiovascular Diabetology. Unidade: FM
Subjects: MODELOS ANIMAIS, RATOS, MIOCÁRDIO, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STRUNZ, Célia M. C. et al. Changes in cardiac heparan sulfate proteoglycan expression and streptozotocin-induced diastolic dysfunction in rats. Cardiovascular Diabetology, v. 10, n. 35, p. 10 , 2011Tradução . . Disponível em: https://doi.org/10.1186/1475-2840-10-35. Acesso em: 02 nov. 2024.APA
Strunz, C. M. C., Matsuda, M., Salemi, V. M. C., Nogueira, A., Mansur, A. P., Cestari, I. N., & Marquezini, M. V. (2011). Changes in cardiac heparan sulfate proteoglycan expression and streptozotocin-induced diastolic dysfunction in rats. Cardiovascular Diabetology, 10( 35), 10 . doi:10.1186/1475-2840-10-35NLM
Strunz CMC, Matsuda M, Salemi VMC, Nogueira A, Mansur AP, Cestari IN, Marquezini MV. Changes in cardiac heparan sulfate proteoglycan expression and streptozotocin-induced diastolic dysfunction in rats [Internet]. Cardiovascular Diabetology. 2011 ; 10( 35): 10 .[citado 2024 nov. 02 ] Available from: https://doi.org/10.1186/1475-2840-10-35Vancouver
Strunz CMC, Matsuda M, Salemi VMC, Nogueira A, Mansur AP, Cestari IN, Marquezini MV. Changes in cardiac heparan sulfate proteoglycan expression and streptozotocin-induced diastolic dysfunction in rats [Internet]. Cardiovascular Diabetology. 2011 ; 10( 35): 10 .[citado 2024 nov. 02 ] Available from: https://doi.org/10.1186/1475-2840-10-35
